Literature DB >> 18255202

Transitory or long-lasting immunity to Leishmania major infection: the result of immunogenicity and multicomponent properties of histone DNA vaccines.

Javier Carrión1, Cristina Folgueira, Carlos Alonso.   

Abstract

The present studies were designed to analyze the immunization against cutaneous leishmaniosis with plasmids encoding Leishmania histones either individually or genetically linked in tandem, or with cocktails encoding the four nucleosomal histones (H2A, H2B, H3 and H4). Genetic immunization of BALB/c mice with the individual histones only resulted in a delay in lesion development, whereas the immunization with any one of the plasmids encoding a pair of histones provided stronger, though still partial protection against Leishmania major infection compared to the combination of the four histones. These results provide direct evidence that all four nucleosomal histones of Leishmania are necessary to maintain complete protection against L. major reinfection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18255202     DOI: 10.1016/j.vaccine.2007.12.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Identifying vaccine targets for anti-leishmanial vaccine development.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Rev Vaccines       Date:  2014-04       Impact factor: 5.217

2.  BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge.

Authors:  Laura Ramírez; Salvador Iborra; Jimena Cortés; Pedro Bonay; Carlos Alonso; Manoel Barral-Netto; Manuel Soto
Journal:  J Biomed Biotechnol       Date:  2010-01-26

3.  Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine.

Authors:  Gustavo Domínguez-Bernal; Pilar Horcajo; José A Orden; Ricardo De La Fuente; Aldara Herrero-Gil; Lara Ordóñez-Gutiérrez; Javier Carrión
Journal:  Vet Res       Date:  2012-08-09       Impact factor: 3.683

4.  Nucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters.

Authors:  Rajendra K Baharia; Rati Tandon; Amogh A Sahasrabuddhe; Shyam Sundar; Anuradha Dube
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

5.  Investigating the Existence of Ribosomal Protein L5 Gene in Syrian Strain of Leishmania tropica Genome: Sequencing It and Evaluating Its Immune Response as DNA Vaccine.

Authors:  Mohammad Maarouf; Alyaa A Abdlwahab
Journal:  J Parasitol Res       Date:  2021-05-20

6.  Vaccination with L. infantum chagasi nucleosomal histones confers protection against new world cutaneous leishmaniasis caused by Leishmania braziliensis.

Authors:  Marcia W Carneiro; Diego M Santos; Kiyoshi F Fukutani; Jorge Clarencio; Jose Carlos Miranda; Claudia Brodskyn; Aldina Barral; Manoel Barral-Netto; Manuel Soto; Camila I de Oliveira
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

7.  Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.

Authors:  Manuel Soto; Laura Corvo; Esther Garde; Laura Ramírez; Virginia Iniesta; Pedro Bonay; Carlos Gómez-Nieto; Víctor M González; M Elena Martín; Carlos Alonso; Eduardo A F Coelho; Aldina Barral; Manoel Barral-Netto; Salvador Iborra
Journal:  PLoS Negl Trop Dis       Date:  2015-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.